HIF1A and Alzheimer disease: On the other hand, HIF1A has also been shown to drive AD pathophysiology through increased production, and/or reduced clearance, of Aβ peptides (Ashok et al., 2016; Pra et al., 2011; Zhang et al., 2007, Kim et al., 2017).